ACN Awards: Enter the Air Cargo Pharma Category

Why It Matters

Recognising pharma‑focused air‑cargo innovation accelerates adoption of safer, greener cold‑chain practices, a critical differentiator as global demand for temperature‑sensitive medicines surges.

Key Takeaways

• ACN Awards open Air Cargo Pharma category for 2026 entries
• Submissions accepted from airlines, forwarders, handlers, GSSAs, airports, brokers
• Judges prioritize original, sustainable solutions with measurable customer benefits
• Entry deadline is 29 May 2026; ceremony on 21 Oct 2026 in London
• Hactl sponsors category, highlighting its 3.5 million‑tonne terminal capacity

Pulse Analysis

The Air Cargo News Awards, now in their 42nd year, have become a benchmark for excellence across the global air‑freight sector. By adding a dedicated Air Cargo Pharma category, the organizers acknowledge the rapid growth of temperature‑sensitive pharmaceuticals, from biologics to vaccines, that rely on precise, rapid air transport. The award’s high‑profile ceremony at London’s Royal Lancaster Hotel underscores the strategic importance of pharma logistics, positioning air cargo as a vital link in the supply chain for life‑saving medicines.

The new category, backed by Hong Kong’s leading handler Hactl, invites a broad spectrum of participants—airlines, forwarders, ground service providers, airports, and brokers—to submit projects launched within the last twelve months. Judges will look for originality, sustainability, and quantifiable benefits such as reduced transit times, lower carbon footprints, or improved temperature compliance. By demanding hard data and customer testimonials, the competition pushes firms to substantiate claims, fostering a culture of transparency and continuous improvement in an industry where regulatory scrutiny is intense.

For companies, a nomination or win can translate into heightened credibility, new business opportunities, and a competitive edge in a market where pharmaceutical shippers are increasingly selective. Hactl’s involvement highlights its massive 3.5 million‑tonne annual capacity and its COSAC‑Plus system, signaling that leading handlers are investing heavily in pharma‑grade infrastructure. As the sector grapples with tighter emissions targets and rising demand for biologics, the ACN Pharma award is likely to catalyze further innovation, encouraging stakeholders to develop greener, more reliable air‑cargo solutions that meet the exacting standards of the healthcare industry.